Art

J-GLOBAL ID：200902267876674465   Reference number：04A0249298

Rationale for the Use of Combination Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Therapy in Heart Failure

心不全におけるアンジオテンシン変換酵素阻害剤とアンジオテンシンII受容体ブロッカーの併用療法の理論的根拠

Author (9)： YASUMURA Y ,  MIYATAKE K ,  OKAMOTO H ,  MIYAUCHI T ,  KAWANA M ,  TSUTAMOTO T ,  KITAKAZE M ,  MATSUBARA H ,  TAKAOKA H
Material： Circulation Journal  (Circ J)
Volume： 68  Issue： 4  Page： 361-366  Publication year： Apr. 2004 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： アンギオテンシン2受容体 ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0249298&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Reference (11)：

• 1. Baruch L, Anand I, Cohen IS, Ziesche S, Judd D, Cohn JN for the Vasodilator Heart Failure Trial (V-HeFT) Study Group. Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure. Circulation 1999; 99: 2658-2664.
• 2. Carson PE. Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure. Am Heart J 2000; 140: 361-366.
• 3. McKelvie RS, Yusuf S, Pericak D, Avezum A, Burns RJ, Probstfield J, et al for RESOLVD Pilot Study Investigators. Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. Circulation 1999; 100: 1056-1064.
• 4. Cohn JN, Tognori G for the Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001; 345: 1667-1675.
• 5. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, et al for the CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin converting-enzyme inhibitors: The CHARM-Added trial. Lancet 2003; 362: 767-771.

Terms in the title (8)： 心不全 ,  アンジオテンシン変換酵素阻害剤 ,  アンジオテンシンII ,  受容体 ,  ブロッカー ,  併用療法 ,  理論 ,  根拠